Dr. Sven Jensen has a Ph.D. in biochemistry/molecular medicine from Harvard Medical School and the University of Bremen. He has over 20 years of experience in the healthcare industry with different C-Level positions in international strategic consultancies like Booz Allen Hamilton (booz&co) in Dubai and global healthcare companies like GE Healthcare in Paris and Chicago as well as CSC/DXC Technology in Germany.

Until April 2022, he had first been CEO and then Executive Board Member of the Munich-based NOVENTI Group. Within the NOVENTI Group, his responsibilities focused on new business innovation, consumer & retail health, health data analytics, digital transformation and sustainability. From mid-2022 he embodied the position of CEO of INNO3 in Leipzig, Germany before joining Neo Q in April of 2023.

Dr. Jansen is an author, keynote speaker and recipient of the LSC Leadership Award of the Vatican. His commitment to planetary health & sustainability is internationally recognized. Due to his scientific and professional career, his industry emphasis includes payer, provider, and public funds as well as life sciences, pharma, biotech/biosimilars and MedTech.